1 mL of product contains Albendazole 25 mg.
Cribendazole 2.5% is a wide-spectrum anthelmintic used in sheep for the prevention (in the population where the diagnosis has been confirmed) and treatment of parasitic infestations caused by larvae and adults of gastrointestinal and pulmonary nematodes, liver cestodes and trematodes: Gastrointestinal roundworms: Ostertagia, Haemonchus, Trichostrongylus. Lung Strongyls: Dictyocaulus viviparus. Cestodosis produced by adult forms of Moniezia spp. Control and treatment of adult forms of Fasciola hepatica.
Do not use in animals with known hypersensitivity to the active substances or to any of the excipients.
No side effects occur at recommended doses.
Treatment is administered orally. The medicine will be measured with a measuring tape or syringe in the amount indicated in the package leaflet. The prevention program should include 4 administrations annually, before starting grazing, after entry into their indoor period and during grazing, in July and September. In the treatment of larval and adult stages of gastrointestinal and pulmonary nematodes, and in the treatment of single-dose cestodoses, 5 mg albendazole/kg live body weight or 2 mL Cribendazol 2.5%/10 kg live body weight. For treatment of hepatic trematodoses caused by Fasciola hepatica, the dose is 7.5 mg albendazole/kg live body weight or 3 mL Cribendazole 2.5%/10 kg live body weight, single dose.
Correct estimate of body weight is recommended to avoid underdosing or overdosing. Shake the vial before use.
Meat and offal: 4 days.
Milk from treated animals shall not be used for human consumption.
Shelf life of the veterinary medicinal product as packaged for sale: 2 years. Shelf-life after first opening the immediate packaging: 28 days.
Keep out of reach of children. Do not store below 25 °C. Do not refrigerate or freeze. Store in the original package. Keep away from light. Store in a dry place. Keep away from direct light.
The following practices, which increase the risk of development of resistance and may ultimately lead to ineffectiveness of treatment should be avoided: too frequent and long-term administration of substances in the same class; underdosing as a result of the wrong weight assessment of the animals. Suspected clinical cases of resistance should be investigated using appropriate tests (e.g., Faecal egg count reduction test). Where the test result suggests resistance to a given substance, another substance belonging to another pharmacological class and other mechanism of action will be used. It is advisable to initiate the treatments after conducting the stool examinations for parasites in conjunction with clinical examinations. If this is not possible, the treatment should be based on local epidemiological information (farm, region).
Avoid direct contact with the skin. Wash your hands after use. When handling the product, wear suitable protective clothing, including waterproof rubber gloves. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. Those with known hypersensitivity to albendazole should avoid contact with the veterinary medicinal product.
The use of the product in pregnant females and breeding rams does not affect breeding performance. Do not use in the first month of gestation. Do not use in sheep producing milk for human consumption.
The recommended doses should be observed.
In the absence of compatibility studies, this veterinary medicinal product will not be mixed with other veterinary medicinal products.
Any unused veterinary medicinal product or waste materials derived from such products should be disposed of in accordance with national requirements. Medicines should not be disposed of via waste water or household waste. Ask your vet for information on how to dispose of medicines no longer required. These measures contribute to environmental protection.
50mL, 100mL and 1L high-density polyethylene vials.